MMCM
NVS icon

Murphy & Mullick Capital Management’s Novartis NVS Stock Holding History

Murphy & Mullick Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$99.3K Hold
650
– – 0.07% 202
2025
Q4 		$89.6K Hold
650
– – 0.06% 212
2025
Q3 		$83.4K Hold
650
– – 0.06% 218
2025
Q2 		$73.9K Hold
650
– – 0.06% 220
2025
Q1 		$72.5K Hold
650
– – 0.07% 216
2024
Q4 		$63.3K Buy
+650
New +$69.3K 0.06% 229

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Murphy & Mullick Capital Management's NVS Position: Q1 2026 in Review

Murphy & Mullick Capital Management held its Novartis (NVS) position steady in Q1 2026 at 650 shares worth $99.3K. The position accounts for 0.07% of the portfolio, ranked #202.

Murphy & Mullick Capital Management first reported a position in NVS in Q4 2024 and has held it in 6 quarters since. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Murphy & Mullick Capital Management held 650 shares of Novartis worth $99.3K as of Q1 2026.
  • Murphy & Mullick Capital Management left its Novartis share count unchanged in Q1 2026.
  • Novartis made up 0.07% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #202 holding.
  • Murphy & Mullick Capital Management first reported a position in Novartis in Q4 2024 and has held it in 6 quarters since.
  • 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.